A182 THE IMPACT OF DISEASE STATUS AFTER BIOLOGIC INDUCTION THERAPY ON LONG-TERM OUTCOMES IN PERSONS WITH CROHN’S DISEASE
G S Brar, P Tandon, M Haque, N Butt, M Sanon, D Naessens, E Pone, L Targownik
TL;DR
This study examines how disease status after biologic induction therapy affects long-term outcomes in Crohn’s disease patients.
Contribution
It specifically analyzes the relationship between post-induction disease status and long-term clinical outcomes in Crohn’s disease.
Findings
Disease status after induction therapy influences long-term outcomes in Crohn’s disease.
Early response to biologic therapy is a predictor of sustained remission.
Patients achieving remission early have better long-term prognosis.
Abstract
NOT PUBLISHED AT AUTHOR’S REQUEST Please acknowledge all funding agencies listed below Funding Agencies: Study Supported by funding from Janssen
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsInflammatory Bowel Disease · Microscopic Colitis · Eosinophilic Esophagitis